CLASS II Drug recall · Reported 13 Aug 2014 · FDA Enforcement Report

L-Carnitine Injection USP 100 mg/ml recalled

Medical Supply Liquidators is recalling L-Carnitine Injection USP 100 mg/ml, distributed nationwide in the US. The recall was initiated on 25 Jun 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lot numbers and exp dates
Quantity recalledN/A

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1532-2014
FDA event ID
68626
Recalling firm
Medical Supply Liquidators, Clive, IA
Classification
Class II
Status
Terminated
Recall initiated
25 Jun 2014
FDA classified
6 Aug 2014
Reported
13 Aug 2014
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Sterility

Timeline

25 Jun 2014Recall initiated by company
6 Aug 2014Classified by FDA+42 days
13 Aug 2014Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

L-Carnitine Injection USP 100 mg/ml, packaged in 30 ml vials, Sterile, For IM or Deep SQ Use, Multiple Dose Vial, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.

Where it was distributed

Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.

Nationwide

Questions about this recall

Is L-Carnitine Injection USP 100 mg/ml recalled?

Yes. Medical Supply Liquidators recalled L-Carnitine Injection USP 100 mg/ml on 25 Jun 2014. The recall is Class II and its status is Terminated. Recall number D-1532-2014.

Why was it recalled?

Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer

Which lots are affected?

All lot numbers and exp dates

Where was it sold?

Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medical Supply Liquidators

All 15

Other L-carnitine recalls

All 3